For the year ending 2025-12-31, ISCO has $4,819K in assets. $4,579K in debts.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash | 993 | |||
| Accounts receivable, net | 723 | |||
| Inventories | 1,514 | |||
| Prepaid expenses and other current assets | 181 | |||
| Total current assets | 3,411 | |||
| Non-current inventories | 229 | |||
| Property and equipment, gross | 2,614 | |||
| Less accumulated depreciation and amortization | 2,454 | |||
| Property and equipment, net | 160 | |||
| Intangible assets, net | 644 | |||
| Right-of-use assets | 344 | |||
| Deposits and other assets | 31 | |||
| Total assets | 4,819 | |||
| Accounts payable | 168 | |||
| Accrued liabilities | 428 | |||
| Operating lease liabilities, current | 393 | |||
| Advances | 250 | |||
| Related party note payable | 3,340 | |||
| Total current liabilities | 4,579 | |||
| Total liabilities | 4,579 | |||
| Series d redeemable convertible preferred stock, 0.001 par value 50 shares authorized 43 shares issued and outstanding liquidation preference of 4,300 at december 31, 2025 and 2024 | 4,300 | |||
| Non-redeemable convertible preferred stock, 0.001 par value 10,004,310 and 10,004,310 shares authorized 5,254,310 and 5,254,310 shares issued and outstanding liquidation preference of 9,826 and 9,811 at december 31, 2025 and 2024, respectively | 5 | |||
| Common stock, 0.001 par value 120,000,000 shares authorized 8,004,389 shares issued and outstanding at december 31, 2025 and 2024 | 8 | |||
| Additional paid-in capital | 107,030 | |||
| Accumulated deficit | -111,103 | |||
| Total stockholders' deficit | -4,060 | |||
| Total liabilities, redeemable convertible preferred stock and stockholders' deficit | 4,819 | |||
International Stem Cell CORP (ISCO)
International Stem Cell CORP (ISCO)